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Abstract 
Transport of cholesterol within multi-cellular organisms is a vital life process. 
Research with  cholesterol transport and metabolism using the Caenorhabditis elegans 
(C. elegans) is beneficial to the health science community because many biological 
processes are conserved between C. elegans and humans. Efficient cholesterol transport 
requires glycosylation, which is the modification of proteins with sugars. In nematodes, 
some of the glycosylated proteins (glycoproteins), called vitellogenins, play a role in 
cholesterol uptake in oocytes of C. elegans. There are a large number of glycosylation 
and cholesterol transport C elegans mutants available. Furthermore C. elegans present an 
unusual research advantage since they cannot synthesize cholesterol and must take it in 
from their outside environment. 
Since C. elegans must take in cholesterol from their outside environment, I 
hypothesized that abnormal glycosylation of vitellogenins impairs the transport of 
cholesterol in C. elegans. I tested this hypothesis with three approaches: quantifying 
cholesterol incorporation into C. elegans oocytes, assaying viability of glycosylation 
defective mutants grown under low or no sterol conditions, and comparing the total 
cholesterol content of glycosylation-defective mutants vs. wildtype animals. 
Through these studies, it was found that 1) srf-8 C. elegans have a significantly 
different accumulation of cholesterol than wildtype worms as determined  by fluorescent 
cholesterol microscopy and, 2) srf-8 C. elegans have a slow hatching phenotype when 
grown in no or low-cholesterol conditions. 
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Introduction 
Humans and the free-living nematode Caenorhabditis elegans (C. elegans) have 
many biological processes conserved between them. This makes C. elegans a useful 
model in the study of human physiology and disease. Cholesterol is an important 
component of eukaryotic cells. It can aid in the structure of the cell membrane by 
affecting the lipid bilayer permeability and making the membrane less fluid
10
. Cholesterol 
is also involved in signaling processes by modulating the cell’s signaling through 
glycolipid-enriched membranes (rafts)
10
. Additionally, C. elegans has played a vital role 
as a model in the study of cholesterol. Cholesterol is thought to be involved in mediating 
membrane structure and raft functions in certain cells, as well as being involved in the 
covalent linkage of signaling proteins in C. elegans
7
. The complete genome of C. elegans 
is known; therefore, this enables researchers to disrupt the genes to see if there is an 
effect on cholesterol metabolism or function . Since C. elegans are not able to synthesize 
sterols within their body; they must therefore get all sterols from their outside 
environment 
7
. This makes C. elegans an ideal model because they can be grown with a 
fluorescent cholesterol-analog with ease. Researchers can also specifically test the effects 
of cholesterol deprivation rather than just general nutrient deprivation.  
Studies have shown that cholesterol plays a vital role in signaling within C. 
elegans 
7
. Previous studies have shown that cholesterol accumulation occurs in C. 
elegans in the pharynx, nerve ring, excretory gland cells, oocytes, spermatozoa and gut of 
L1-L3 larvae
10
. The uptake and transport of cholesterol into the oocytes, a major 
accumulation site, of C. elegans occurs via an endocytotic pathway. This pathway uses 
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yolk proteins to aid in endocytosis
10
 . The yolk is a lipoprotein that is made of lipids and 
lipid-binding proteins 
4
. The yolk proteins are called vitellogenins. In order for 
cholesterol to be transported into the oocytes, vitellogenin-2 (VIT-2) must bind to the 
receptor, RME-2.  
Fluorescent analogs of cholesterol can be used to image cholesterol spatial 
distribution within tissues or cells. Dehydroergosterol (DHE) (Figure 1B) is a naturally-
occurring, fluorescent analog of cholesterol that mimics many of cholesterol’s properties. 
Previous studies have shown that DHE , like cholesterol, accumulates in tissues such as 
the nerve ring, spermatheca and oocytes in C. elegans
14
. However, DHE has been shown 
to cause complications during fluorescent imaging of C. elegans due to the C. elegans 
having a high autofluorescence produced at the same spectrum that DHE is emitted at
14
. 
Fluorescent boron dipyrromethene difluoride linked to sterol carbon-24 
(BODIPY-cholesterol) (Figure 1C) is a synthetic cholesterol analog. This cholesterol 
analog has been used to observe sterol movement in mammalian cells
5
. Fluorescent 
BODIPY-cholesterol is useful due to its high photostability. In a study performed on 
Zebrafish, BODIPY-cholesterol allowed for growth and viability of the cell in the same 
way cholesterol and DHE did. Additionally, it was easier to visualize than DHE
5
. 
It is known that C. elegans must take in all sterols from their outside environment. 
We hypothesized that glycosylation defects may alter cholesterol endocytosis in C. 
elegans for several reasons. First, other studies have shown that some of the phenotypes 
of the srf-3 and srf-8 mutants have an overlap with the phenotypes of cholesterol-
deprived wildtype worms. Previous studies showed that srf-3 and srf-8 dauer animals 
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grown under regular cholesterol conditions showed a SDS-sensitivity resembling the one 
that is seen in cholesterol deprived wildtype dauers
9
.  srf-8 C. elegans grown under 
regular cholesterol conditions also express gonadal arm migration (distal tip cell 
migration) defects
9
. This distal tip cell migration defect is expressed in cholesterol 
deprived wildtype animals
11
. Niemann-Pick proteins are involved in cholesterol transport. 
C. elegans that exhibit defects in the Niemann-Pick proteins appear to have distal tip cell 
migration defects as well
8
. Data from the Berninsone lab suggests that srf-3 animals have 
differently glycosylated VIT-2 and VIT-6 than wildtype animals (Data came from a 
azido-GalNAc metabolic labeling followed by 2D gel electrophoresis and mass 
spectrometry identification of the candidate proteins, performed by Amanda Marusich). 
This study looks at the total cholesterol incorporation and distribution in wildtype 
and glycosylation-defective mutant C. elegans. It utilized previous methods for spatial 
cholesterol imaging and quantitation of cholesterol incorporation using DHE. In addition, 
we developed a method for using BODIPY-cholesterol to track cholesterol accumulation 
and transport in C. elegans with fluorescent microscopy. The study specifically looked at 
the distribution of cholesterol in the oocytes of the nematode. Bioassays were also 
performed to compare the viability of glycosylation mutants that were grown under no 
cholesterol conditions. Lastly, the study set up pilot tests for  a biochemical approach  to 
quantify cholesterol within different glycosylation-defective mutants by using Amplex 
Red and the Bradford Assay to compare the milligrams of cholesterol per milligrams of 
total protein in worms. 
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The studies determined that srf-8 C. elegans had  significantly different 
accumulation of cholesterol than compared to wildtype worms. They also indicated that 
the srf-8 C. elegans have a slow hatching phenotype when grown under low cholesterol 
conditions. This is due to the srf-8 worms having a decreased hatch rate after 26 hours 
compared to wildtype; however, all srf-8 eggs had hatched within 72 hours. 
Materials and Methods 
C. elegans maintenance and strains used 
The wildtype strain and glycosylation mutants (srf-3(yj10), srf-3 (br6), rme-2 
(b1008) and srf-8) were obtained from the Caenorhabditis Genetics Center (CGC) and 
maintained on NGM (Nematode Growth Media) plates as described 
1
.  
Labeling C. elegans with DHE  
Bacteria containing DHE was prepared as directed 
10
.  An equal volume of E. coli 
and 5mM DHE in ethanol were mixed. The mixture was dialyzed in water twice; the first 
time was for 3-4 hours, then the cassette was placed in fresh water to dialyze overnight. 
After dialyzing, the mixture was combined with live OP50 strain E. coli. Concentrations 
of 1:5 and 1:25 bacteria containing DHE and live  E. coli of the OP50 strain were used. 
Bacterial lawns were  grown overnight at 16°C. Gravid adults from each strain (wildtype 
(N2), srf-3, srf-8 and rme-2) were put on plates and left to mature at 20°C for 3 days. The 
worms were washed off the plates with M9 and pelleted by spinning for 3 minutes at 250 
x g and 10°C. Supernatant was removed, and the pellet of worms was resuspended in 1ml 
of 10mM sodium azide in M9. Worms were placed on top of agarose pads on microscope 
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slides, and a cover slip was placed over them. It was important to prepare and keep the 
worms in a dark environment so the DHE fluorescence did not fade. Worms were 
analyzed using  an Olympus BX60 microscope fitted with an Olympus DP-70 camera. A 
UV mercury lamp was used with a DAPI (N31000) filter cube. The image acquisition 
software used was DP Controller Software (Olympus). 
Preparation of BODIPY-cholesterol and Labeling of C. elegans 
NGM plates were made and either cholesterol solubilized in ethanol or no 
cholesterol (i.e., ethanol alone), was added. NGM plates were seeded with a drop of 
OP50 bacteria, as is done with mating plates. BODIPY-Cholesterol was obtained from 
Avanti Polar Lipids Inc. The desired dilution of BODIPY-Cholesterol in DMSO was a 
concentration of 50μM for the experiment. 
250μL of 50μM BODIPY-cholesterol/DMSO solution was placed on top of the 
OP50 bacterial lawns of each agarose plate and allowed to dry in the dark. Mixed stage 
worms from normal NGM-lite plates were put onto plates containing the BODIPY-
Cholesterol. The plates were kept in the dark at 20°C for 24 hours. Once the worms had 
grown and incorporated the BODIPY-Cholesterol, they were ready for imaging.  
In order to image, a sucrose flotation was performed to separate the worms from 
the bacteria. The sucrose flotation was modeled after the Koelle lab protocol 
6
. The 
worms were washed off the plates with M9 and pelleted by spinning for 3 minutes at 250 
x g and 10°C. The supernatant was poured off, and the pellets were chilled on ice for 5 
minutes. The pellet of worms was resuspended in 4-5mL of 0.1 M NaCl and spun at 250 
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x g for 3 minutes. Supernatant was poured off after spinning, leaving a little liquid 
behind. The pellet of worms was chilled on ice for 5 minutes. The tube was swirled to 
resuspend the pellet, and a solution of one part 0.1M NaCl and one part 60% sucrose was 
added to the tube. Once the solution was added, the worms were evenly mixed into 
solution, and the tube was spun at 250 x g for 3 minutes with a slowdown period of 2 
minutes. After spinning, the pellet was chilled on ice for 5 minutes. There was a dark 
pellet at the bottom of the tube containing  bacteria, debris and dead worms. Furthermore, 
there was a light brown layer at the top of the tube which was comprised of live worms. 
The layer of live worms was removed and placed in a new centrifuge tube. The worm 
suspension was diluted four-fold in ice cold 0.1M NaCl and spun at 250 x g for 3 
minutes. The supernatant was removed, and the worms were ready for imaging. 
Imaging BODIPY labeled C. elegans 
The worms were imaged using a confocal microscope, fluorescence excitation 
ranged from 510nm to ~665NM
12
. The images were processed with Olympus Fluo View 
Software and quantitatively analyzed with ImageJ Software.  
Low Cholesterol v. High Cholesterol Bioassay 





 media. Agarose plates were seeded with 75μL of OP50 bacteria prepared 
according to the Crowder or Yochem procedure. Synchronized worms were used for the 
assay. Worms were synchronized by an embryo flotation as described 
13
. Alterations to 
the flotation procedure for these experiments included:  replacing the egg buffer with M9, 
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using a 60% sucrose solution, and rinsing the eggs collected from the sucrose flotation. 
The 15mL tube containing the collected eggs had sterile water added to the tube, and the 
eggs were pelleted by spinning at 210 x g for 4 minutes. The spinning allowed all the 
eggs to sediment to the bottom. After the supernatant was pipetted off and the eggs were 
resuspended in a small amount of M9, the eggs were then put onto NGM lite plates with 
5μg/ml cholesterol. 
Once the eggs were put on plates they were grown at 16°C for 48 hours and 
became L4 stage C. elegans. 20-30 worms from each strain were put onto unseeded 
plates for 30 minutes. This allowed them to move around the plates and remove any 
bacteria that may have been on the worms. 10-15 worms from each strain were placed on 
experimental and control plates. The experimental plates were made with Crowder or 
Yochem media and did not contain cholesterol. The control plates were made from 
Crowder or Yochem media as well, but were supplemented with 5μg/ml cholesterol. The 
worms were grown at 16°C for 48 hours to become gravid adults. Once they were gravid 
adults, they were placed on new experimental and control plates. The worms laid eggs for 
5 hours, and all the gravid adults were removed from the plates. Then, the numbers of 
eggs on the plates were counted. Plates were stored at 16°C for 26 hours to allow the 
eggs to hatch. After 26 hours, the eggs that had not hatched were counted, and the 
numbers were compared to determine the hatch rate of the different strains under the 
different cholesterol conditions. 
Cholesterol Extraction from Agarose 
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Cholesterol was extracted from the agarose in 10X volume of 1:2 mixture of 
CHCl3 
3
.  The agarose extraction was performed 3 times. The extracted agarose was left 
sitting in the fume hood overnight to dry in glass containers with kimwipes covering 
them. 
Cholesterol Quantitation Assay 
For each strain synchronized populations of worms were obtained by washing all 
the worms off of plates that had eggs laid on them using M9. The eggs were left at 16°C 
to allow the worms to hatch. Once all eggs had hatched and become L1 stage worms, 
after approximately 24 hours, they were washed off the plates with M9, pelleted, and 
placed on fresh plates. On the fresh plates, the worms were allowed to grow into gravid 
adults. Once mature, they were washed off the plates with M9 and pelleted. The worms 
were rinsed in large volumes of ice-cold M9 5 times. The supernatant of the last wash 
was saved for a blank in quantitation. The cholesterol quantitation assay was performed 
as described 
2
, using Amplex Red as a fluorescent reporter of cholesterol content.  
Results 
Cholesterol localization and accumulation in C. elegans embryos as determined by DHE 
fluorescence 
The first part of this study used fluorescent analogs of cholesterol to visualize the 
amount and spatial incorporation of cholesterol in wildtype and mutant strains of C. 
elegans. DHE is a naturally occurring fluorescent analog of cholesterol. Previous studies 





   
imaging, the worms that had DHE incorporated in them emitted too much 
autofluorescence at the same wavelength DHE was emitted (Data not shown). Due to the 
abundance of autofluorescence, other cholesterol visualization methods were pursued. 
Cholesterol localization and accumulation in C. elegans embryos as determined by 
BODIPY-cholesterol fluorescence 
BODIPY-cholesterol is a synthetic fluorescent analog of cholesterol. Previous 
studies used BODIPY-cholesterol to visualize and monitor cholesterol movement in 
mammalian cells. It was also shown to be highly photostable and fluorescence was 
emitted at a different wavelength than C. elegans autofluorescence. A protocol was 
developed to incorporate the BODIPY-cholesterol in place of cholesterol in the wildtype 
and mutant strains of C. elegans. When the worms were imaged, BODIPY-cholesterol 
was incorporated in the worms and could be visualized (Figure 2). Looking at the 
wildtype worms, BODIPY-cholesterol was seen in the oocytes and spermatheca. This is 
where other studies had suggested cholesterol was localized (Figure 2A, B). In contrast, 
rme-2 C. elegans mutants showed very little BODIPY-cholesterol incorporated in their 
oocytes and spermatheca (Figure 2C, D). This is consistent with the fact these mutants 
have a disruption in the vitellogenin receptor (RME-2) and have been shown to have very 
little cholesterol accumulation
10
. The mutant strain (srf-3 and srf-8) worms also showed 
incorporation of cholesterol in their oocytes and spermatheca (Figure 2E-J). 
After images were taken, the fluorescence in the oocytes was quantititated using 
imageJ software. Wildtype, rme-2, and srf-8 C. elegans had a similar distribution pattern 
for the total amount of BODIPY-fluorescence incorporated into each oocyte (Figure 3, A-
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C). The distribution of the fluorescence intensity of the oocytes was different between the 
wildtype and srf-3 C. elegans (Figure 3, B and D). There was a wide variation in 
fluorescent intensity of gastrulated embryos for srf-3 worms (Figure 2, I-J; Figure 3D). 
Some srf-3 gastrulated embryos showed much greater fluorescence than the wildtype 
gastrulated embryos.  
The mean fluorescence of gastrulated embryos in C. elegans strains was 
compared (Figure 4). The srf mutant strains were compared to the wildtype worms using 
the Mann-Whitney test. The test showed a significant difference of median fluorescence 
between the srf-8 and wildtype C. elegans (Figure 4).This suggests that the srf-8 
mutation, which leads to an abnormal glycosylation profile in srf-8 worms, also leads to 
an abnormal cholesterol-loading phenotype. 
Slow-hatch rate phenotype as determined by C. elegans bioassays 
The second part of the study used bioassays to determine if cholesterol is 
necessary for the viability of C. elegans. A variety of media was tested to find the best 
conditions on which to grow the C. elegans. The first media used was the Crowder 
media. Literature had shown C. elegans to grow successfully on Crowder media plates 
3
. 
When the Crowder media was used for the bioassay, there was an extreme decrease in 
growth of the worms; the C. elegans took longer to become gravid adults and appeared 
smaller than gravid adults grown on NGM stock plates. Crowder plates also had a lower 
survival and hatch rate. Surprisingly, in experiments using animals grown on Crowder 
plates for additional generations, the animals on the Crowder plates with cholesterol had 
a lower hatch rate than the Crowder plates without cholesterol (Data not shown).  
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In the next pilot trial, a variety of media was tested. Media included Yochem 
media with OP50 bacteria, NGM-lite media with Crowder OP50, and NGM-lite media 
with regular OP50. Yochem media allowed for normal growth of C. elegans, and further 
bioassays were performed using Yochem media with regular OP50 bacteria.  
Preliminary data for the hatch rate bioassay shows that srf-8 had a lower hatch 
rate after the first 26 hours, as compared to wildtype C. elegans (Figure 5). Even when 
Crowder plates were used for the bioassay and complications occurred, there was a 
decrease in the hatch rate after the first 26 hours (Figure 5A). NGM-lite media without 
cholesterol also showed a decrease in the hatch rate for srf-8 compared to wildtype after 
the first 26 hours (Figure 5B). The bioassays that were performed using Yochem media 
showed an even greater decreased hatch rate than NGM-lite after the first 26 hours for 
srf-8 compared to wildtype (Figure 5C). The hatch rate decrease between NGM-lite 
media and Yochem media is most likely due to Yochem media having less cholesterol 
than NGM-lite media (Figure 5B, C). After 72 hours the plates were checked. At this 
time, all the eggs that were laid on the srf-8 plates had hatched. This showed that there is 
not a viability phenotype in the srf-8. Rather, there is a slow hatching phenotype that 
occurs when srf-8, but not wildtype, C. elegans are deprived of cholesterol. Further 
bioassays are being performed to expand our data on the slow hatching phenotype in 
order to test the statistical significance of these findings. 
Discussion 
Since C. elegans must take in sterols from the outside environment, there is a 
possibility that glycosylation defects may alter the nematodes ability to endocytose 
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cholesterol. This was analyzed by studying the incorporation and distribution of 
cholesterol in C. elegans. There appeared to be a cholesterol incorporation phenotype in 
the srf-8 C. elegans. This was evidenced by the significant difference of cholesterol 
accumulation in gastrulated embryos of the srf-8 and wildtype strains. The phenotype 
was also evidenced in the bioassay experiments. The srf-8 strain had a lower hatch rate 
than wildtype after the first 26 hours; however, within 72 hours all eggs had hatched. 
This suggested that cholesterol deprivation did not result in a viability difference but 
rather a slower hatch rate phenotype. 
The studies showed cholesterol accumulation in the oocytes and spermatheca. 
This is in concurrence with previously published literature. Since there was a lower 
accumulation of BODIPY-cholesterol in srf-8, and the bioassay showed a cholesterol-
deprivation phenotype in srf-8, it appears that defects in this mutant C. elegans lead to an 
altered ability to endocytose cholesterol. 
The future goals of this study would be to complete double mutant C. elegans 
crosses and quantitate the amount of cholesterol per protein found in each strain of C. 
elegans studied. Steps have already been made to cross srf-3(yj10), srf-3 (br6), and srf-8 
worms with a vit-2::GFP worm, which carries a translational VIT-2-GFP fusion 
construct. The cross of these strains would allow the VIT-2 protein to be localized in the 
srf strains. Vitellogenin 2 would fluoresce in each strain once crossed with vit-2::GFP, 
and images could be taken. If Vitellogenin 2 is mislocalized in the srf mutants, it would 




   
Another part of the study that is in progress is the quantitation of cholesterol in C. 
elegans strains.  An Amplex Red Cholesterol Kit, provided by Invitrogen, is used to 
quantitate the cholesterol. By coupling this kit with the Bradford total protein quantitation 
method, the amount of cholesterol per amount of total protein in each strain of worm will 
be able to be quantified. Once the amount of cholesterol is quantitated there will be a 
better understanding as to if there is a deficiency in cholesterol endocytosis due to 
mutations in the srf genes.  
The mechanism behind cholesterol transport within C. elegans will be beneficial 
to the health science community. A better understanding of cholesterol transport in C. 
elegans leads to knowledge of cholesterol transport and function in Eukaryotic cells. 
Studying cholesterol transport and the mechanics of it will help to control metabolic 
disorders that lead to cholesterol problems in humans.  
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